In line with these findings, silencing of SOX9 diminished viability of breast cancer cells and reduced invasion in vitro and in vivo by enhancing the expression of apoptosis related genes such as FADD, while decreasing the expression of genes involved in epithelial–mesenchymal transition like ZEB1 or CTNNB1 [5]. Here, SOX9 is linked to breast cancer.